Acute Treatment of Stroke (Except Thrombectomy)

Curr Neurol Neurosci Rep. 2018 Sep 18;18(11):77. doi: 10.1007/s11910-018-0883-x.

Abstract

Purpose of review: The management of patients with acute stroke has been revolutionized in recent years with the advent of new effective treatments. In this rapidly evolving field, we provide an update on the management of acute stroke excluding thrombectomy, looking to recent, ongoing, and future trials.

Recent findings: Large definitive trials have provided insight into acute stroke care including broadening the therapeutic window for thrombolysis, alternatives to standard dose alteplase, the use of dual antiplatelet therapy early after minor ischemic stroke, and treating elevated blood pressure in intracerebral hemorrhage. Further ongoing and future trials are eagerly awaited in this ever-expanding area. Although definitive trials have led to improvements in acute stroke care, there remains a need for further research to improve our understanding of pathophysiological mechanisms underlying different stroke types with the potential for treatments to be tailored to the individual.

Keywords: Acute ischemic stroke; Antiplatelets; Blood pressure; Intracerebral hemorrhage; Stroke unit; Thrombolysis.

Publication types

  • Review

MeSH terms

  • Brain Ischemia / diagnosis
  • Brain Ischemia / drug therapy*
  • Cerebral Hemorrhage / diagnosis
  • Cerebral Hemorrhage / drug therapy
  • Clinical Trials as Topic / methods
  • Critical Care / methods
  • Fibrinolytic Agents / therapeutic use
  • Humans
  • Platelet Aggregation Inhibitors / therapeutic use
  • Stroke / diagnosis
  • Stroke / drug therapy*
  • Thrombectomy*
  • Thrombolytic Therapy / methods*
  • Tissue Plasminogen Activator / therapeutic use

Substances

  • Fibrinolytic Agents
  • Platelet Aggregation Inhibitors
  • Tissue Plasminogen Activator